Portfolio Lab

Liquidia Corp

  • Stock
  • Ticker LQDA
  • ISIN US53635D2027
  • Nasdaq

Health care · Pharmaceuticals · USA

$54.43 −3.88%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Liquidia Corp since 07/2018, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

LQDAGlobal equities (VT)

$10,000 grew to $145,147. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −93.9% in 08/2021, measured from the peak in 10/2018. It took 87 months to get back to the old peak.

1-year return
+90.6%
5-year return p.a.
+66.5%
Return p.a. since 07/2018
+21.1%
Volatility p.a.
86.0%
Largest decline
−93.9%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue2.93.18.85492133172225
Gross profit1.61.6––––––
Operating income-36-35-381.8206286-264
EBITDA-36-35-372.1206286-263
Net income-39-38-42-3.5155375-236
Earnings per share-0.45-0.45-0.49-0.040.170.520.74-2.64
Balance sheet
Total assets230227257276328402522683
Liabilities151178242254283293327708
Equity7950152245109195-25
Cash176170173157191223284396
Cash flow
Operating cash flow-21-31-39-9.8445380147
Capital expenditure-1.3-0.3-1.1-0.9-2.0-2.8-11-17
Free cash flow-22-31-41-11425069130

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +193.3%, weakest 2019 at −80.3%. 4 of 7 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
10 Nov 2026−$2.64
12 Aug 2026$0.74
11 May 2026$0.52
5 Mar 2026$0.17
3 Nov 2025−$0.04
12 Aug 2025−$0.49
8 May 2025−$0.45
19 Mar 2025−$0.45
13 Nov 2024−$0.40
7 Aug 2024−$0.38
13 May 2024−$0.40
13 Mar 2024−$0.43

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€4.4bn
Market cap in trading currency
$4.90bn
Enterprise value
$4.51bn
P/E
–
P/S
7.89
P/B
–
EV/Sales
7.25
EV/EBITDA
–
Earnings yield
–
FCF yield
5.9%

Results (last four quarters)

Revenue
$622m
Gross profit
–
EBITDA
−$95.4m
Net income
−$94.2m
Earnings per share
−$1.21
Revenue per share
$6.90
Revenue growth
+314.6%
Earnings growth
–

Profitability

Gross margin
–
Operating margin
-15.6%
Net margin
-15.1%
Return on equity
–
Return on assets
-13.8%

Balance sheet and cash flow

Cash
$396m
Cash per share
$4.40
Financial debt
–
Debt/equity %
–
Current ratio
1.02
Book value per share
−$0.28
Operating cash flow
$324m
Free cash flow
$291m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
90.1m
Volume
1.67m
Avg. volume 3 months
3.53m
Relative volume
0.5

Price and technicals

Price
$54.43
1 day
−3.9%
52-week high
$91.03
52-week low
$25.91
Distance to 52-week high
−40.2%
Distance to 52-week low
+110.1%
Distance to 50-day line
+13.9%
Distance to 200-day line
−1.1%
RSI (14)
59
Volatility 1M
76.4%

Performance

1 week
−5.2%
1 month
+37.1%
3 months
−22.5%
6 months
−10.7%
YTD
+57.8%
1 year
+83.6%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has LQDA performed since 07/2018?

$10,000 grew to $49,036 by 20 Nov 2026, which is +21.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is LQDA?

Volatility was 86.0% per year, measured on monthly returns. The largest decline from a peak was −93.9%, with the low in 08/2021.

How does LQDA compare with a broad equity ETF?

Over the same period Global equities (VT) returned +10.1% per year at 16.3% volatility, LQDA returned +21.1% at 86.0%. The correlation of monthly returns was 0.03; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Liquidia Corp (LQDA): Return and risk | Portfolio Lab